Thermo Fisher and the Cell and Gene Therapy Catapult Collaborate to Optimise Advanced Therapy Supply Chain
To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific,...
To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific,...
Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for...
BioSig Technologies, Inc , a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an...
QR Pharma, Inc., a privately held phase 2 biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s (AD), Parkinson’s...
Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an...
Catalyst Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular and...
The last decade has seen an increased emphasis on research and development into personalized medicines,including cell, gene and immunotherapy treatments...
Tonix Pharmaceuticals Holding Corp. , a company that is developing innovative pharmaceutical products to address public health challenges, working with...
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. announced that...
Liquid Learning is delighted to present the Women in Pharma and Medical Leadership Summit. A unique platform in New Zealand...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.